Cornerstone Wealth Group’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,026,327
Closed -$20.1M 276
2024
Q3
$20.1M Buy
+1,026,327
New +$20.4M 1.66% 9
2023
Q2
Sell
-449,268
Closed -$9.17M 147
2023
Q1
$9.17M Buy
+449,268
New +$9.04M 1.63% 11
2022
Q4
Sell
-412,105
Closed -$8.38M 136
2022
Q3
$8.38M Buy
+412,105
New +$8.21M 1.85% 11
2022
Q2
Sell
-298,904
Closed -$5.48M 133
2022
Q1
$5.48M Buy
+298,904
New +$5.51M 1.01% 23

Other funds holding BTAL

Cornerstone Wealth Group's BTAL Position: Q4 2024 in Review

Cornerstone Wealth Group sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2024, closing a stake of 1,026,327 shares — an estimated $20.1M sold.

Cornerstone Wealth Group first reported a position in BTAL in Q1 2022 and held it in 4 quarters. The position peaked at $20.1M in Q3 2024. 68 funds tracked by Wall St. Rank hold BTAL as of Q4 2024.

  • Cornerstone Wealth Group reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2024 after selling out during the quarter.
  • Cornerstone Wealth Group sold 1,026,327 AGF US Market Neutral Anti-Beta Fund shares in Q4 2024, an estimated $20.1M.
  • Cornerstone Wealth Group first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2022 and held it in 4 quarters.
  • Cornerstone Wealth Group's AGF US Market Neutral Anti-Beta Fund position peaked at $20.1M in Q3 2024.
  • 68 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2024.

Based on Cornerstone Wealth Group's 13F filing for Q4 2024, filed 22 Jan 2025.